SEC Form D · filed January 26, 2017
Matinas BioPharma Holdings, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (25)
David Orfao · Boston, MAExec · DirectorHerbert A. Conrad · Bedminster, NJDirectorJerome A. Jabbour · Bedminster, NJExecJames F. Scibetta · Bedminster, NJDirectorRaphael J. Mannino · Bedminster, NJExecPaula Long · Boston, MADirectorEllen Rubin · Boston, MAExec · DirectorLazarus Vekiarides · Boston, MAExec · DirectorMantford C. Hawkins · Fort Worth, TXDirectorQiang Li · PALO ALTO, CAExecCapital Management LLC Glenville · Greenwich, CTDirectorJay Leon · Seattle, WAExec · DirectorBrook T. Byers · Menlo Park, CAExecRay A. Smith · Irvine, CAExecRoelof Rongen · Bedminster, NJExec · DirectorDouglas F. Kling · Bedminster, NJExecAdam A. Stern · Bedminster, NJDirectorAbdel A. Fawzy · Bedminster, NJExecSean Dalton · Boston, MAExecXuecheng Jin · Menlo Park, CAExecMing Shan · Menlo Park, CADirectorGary A. Gaglione · Bedminster, NJExecStefano A. Ferrari · Bedminster, NJDirectorJitendra Saxena · Boston, MAExec · DirectorAdam D. Egelberg · Greenwich, CTExec Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗